An Efficacy and Safety Study of GNR-068 (Ustekinumab Biosimilar) and Stelara® in the Treatment of Patients With Moderate to Severe Plaque Psoriasis
Clinical trial NCT06488664 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06488664
- Sponsor
- AO GENERIUM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-25
- Primary completion
- 2025-04-30
- Enrollment
- 422
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.